Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-030858
Filing Date
2015-05-14
Accepted
2015-05-14 17:29:30
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v409526_10q.htm 10-Q 326098
2 EXHIBIT 31.1 v409526_ex31-1.htm EX-31.1 10298
3 EXHIBIT 31.2 v409526_ex31-2.htm EX-31.2 10109
4 EXHIBIT 32.1 v409526_ex32-1.htm EX-32.1 6192
  Complete submission text file 0001144204-15-030858.txt   4627066

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT iliu-20150331.xml EX-101.INS 598295
6 XBRL TAXONOMY EXTENSION SCHEMA iliu-20150331.xsd EX-101.SCH 44207
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE iliu-20150331_cal.xml EX-101.CAL 29326
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE iliu-20150331_def.xml EX-101.DEF 277427
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE iliu-20150331_lab.xml EX-101.LAB 306367
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iliu-20150331_pre.xml EX-101.PRE 307581
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Filer) CIK: 0001037649 (see all company filings)

EIN.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32715 | Film No.: 15864181
SIC: 2835 In Vitro & In Vivo Diagnostic Substances